Cargando…
Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival
Semaphorin-3E (Sema3E) is a member of an axon guidance gene family, and has recently been reported to contribute to tumor progression and metastasis. However, its role in pancreatic cancer is yet unknown and uncharacterized. In this study, we showed that Sema3E is overexpressed in human pancreatic c...
Autores principales: | Yong, Lin-Kin, Lai, Syeling, Liang, Zhengdong, Poteet, Ethan, Chen, Fengju, van Buren, George, Fisher, William, Mo, Qianxing, Chen, Changyi, Yao, Qizhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349999/ https://www.ncbi.nlm.nih.gov/pubmed/27911862 http://dx.doi.org/10.18632/oncotarget.13704 |
Ejemplares similares
-
Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib
por: Poteet, Ethan, et al.
Publicado: (2019) -
Sublingual Immunization with Chimeric C1q/CD40 Ligand/HIV Virus-like Particles Induces Strong Mucosal Immune Responses against HIV
por: Liu, Dongliang, et al.
Publicado: (2021) -
Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2016) -
Overexpression of Semaphorin 3A is a Marker Associated with Poor Prognosis in Patients with Nasopharyngeal Carcinoma
por: Imoto, Tomoko, et al.
Publicado: (2020) -
Reduced Selenium-Binding Protein 1 in Breast Cancer Correlates with Poor Survival and Resistance to the Anti-Proliferative Effects of Selenium
por: Zhang, Sheng, et al.
Publicado: (2013)